NYSE: CVS

CVS Health Corporation

Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of CVS Health Corporation (NYSE: CVS) between February 9, 2022 and April 30, 2024, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than September 10, 2024.

If you purchased CVS securities and would like to join the action, please click “Join This Class Action.”

Class Period:February 9, 2022 through April 30, 2024
If you purchased CVS securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
Contact Us

Details of the case:

According to the lawsuit, throughout the Class Period, defendants made false and/or misleading statements and/or failed to disclose that:

  • CVS had deficient internal controls;
  • as a result of its deficient internal controls, CVS’s financial statements for the fiscal year 2022 contained false and/or misleading information;
  • as a result of its deficient internal controls, the forecasts CVS used to determine plan premiums were ineffective at accounting for medical cost trends and health care utilization patterns;
  • as a result, CVS was likely to incur significant expenses to cover cost increases that were not accounted for in the CVS’ forecasts and thus not covered by plan premiums;
  • accordingly, CVS had overstated the profitability of its Health Care Benefits segment;
  • contrary to defendants’ assurances, the revenues generated from CVS’ other primary segments were insufficient to offset the negative financial impact of the increasing expenditures within the Health Care Benefits segment; and
  • as a result, CVS’ public statements were materially false and misleading at all relevant times.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Follow us on:
Company Name: CVS Health Corporation
Stock Symbol: CVS
Class Period: February 9, 2022 through April 30, 2024
Court: United States District Court for the Southern District of New York

The Rosen Law Firm has been ranked among the top 4 law firms each year since 2013 for the number of successful securities class actions on behalf of investors. In 2019 alone, our firm recovered $438 million for investors.

Investors should carefully identify and select experienced counsel with a track record of success leading securities class actions. Often other firms issue press releases about class actions yet do not have comparable experience or resources.

Institutional Shareholders Services ranked the Rosen Law Firm # 1 for the number of securities class action recoveries in 2017.

The Rosen Law Firm represents investors throughout the globe. Our mission is to prosecute securities fraud class actions and protect shareholders’ rights.

Rosenlegal
Scroll to Top